Ever Source Wealth Advisors, LLC Biocryst Pharmaceuticals Inc Transaction History
Ever Source Wealth Advisors, LLC
- $1.66 Billion
- Q1 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 1,070 shares of BCRX stock, worth $11,748. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,070
Previous 150
613.33%
Holding current value
$11,748
Previous $1,000
700.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding BCRX
# of Institutions
293Shares Held
177MCall Options Held
721KPut Options Held
489K-
Vanguard Group Inc Valley Forge, PA21.7MShares$238 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$219 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.93MShares$98 Million5.64% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.7MShares$95.5 Million1.06% of portfolio
-
State Street Corp Boston, MA7.81MShares$85.8 Million0.0% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $2.04B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...